Since the seminal work of Weinstein and Stason2 in 1977, thousands of cost-effectiveness analyses (CEAs) have been performed to evaluate diagnostic and therapeutic strategies in virtually all disciplines of medicine. Concern about a lack of methodological standards prompted the US Public Health Service to empanel a group to develop standards for the conduct and reporting of a CEA in 1993. Article available for purchase now, find out more here. (Source: Mark S. Roberts, JAMA, 9/13/16)
Health Outcomes, Market Access, and HEOR Global News Resources and Jobs.
